ロード中...
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
FMS-like tyrosine kinase 3- internal tandem duplication (FLT3-ITD) remains as one of the most frequently mutated genes in acute myeloid leukemia (AML), especially in those with normal cytogenetics. The FLT3-ITD and FLT3-TKD (tyrosine kinase domain) mutations are biomarkers for high risk AML and are...
保存先:
| 出版年: | Biomark Res |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6737601/ https://ncbi.nlm.nih.gov/pubmed/31528345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-019-0170-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|